Agerbo, E, Sullivan, PF, Vilhjálmsson, BJ, et al. (2015) Polygenic risk score, parental socioeconomic status, family history of psychiatric disorders, and the risk for schizophrenia: a Danish population-based study and meta-analysis. JAMA Psychiatry, 72: 635–41.
Baker, K, Costain, G, Fung, WLA, et al. (2014) Chromosomal microarray analysis – a routine clinical genetic test for patients with schizophrenia. Lancet Psychiatry, 1: 329–31.
Bao, Y, Ibram, G, Blaner, WS, et al. (2012) Low maternal retinol as a risk factor for schizophrenia spectrum disorders in adult offspring. Schizophrenia Research, 137: 159–65.
Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium (2018) Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes. Cell, 173: 1705–15.
Byars, SG, Boomsma, JJ (2016) Opposite differential risks for autism and schizophrenia based on maternal age, paternal age, and parental age differences. Evolution, Medicine and Public Health, 1: 286–98.
Cai, L, Wan, CL, He, L, et al. (2015) Gestational influenza increases the risk of psychosis in adults. Medicinal Chemistry, 11: 676–82.
Cederlöf, M, Ohlsson Gotby, A, Larsson, H, et al. (2014) Klinefelter syndrome and risk of psychosis, autism and ADHD. Journal of Psychiatric Research, 48: 128–30.
Chu, CS, Chow, PC, Cohen-Woods, S, et al. (2017) The DAOA gene is associated with schizophrenia in the Taiwanese population. Psychiatry Research, 252: 201–7.
Firth, J, Carney, R, Stubbs, B, et al. (2018) Nutritional deficiencies and clinical correlates in first-episode psychosis: a systematic review and meta-analysis. Schizophrenia Bulletin, 44:1275–92.
Fountoulakis, KN, Gonda, X, Siamouli, M, et al. (2018) Paternal and maternal age as risk factors for schizophrenia: a case-control study. International Journal of Psychiatry in Clinical Practice, 22: 170–6.
Fusar-Poli, P, Borgwardt, S, Crescini, A, et al. (2011) Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neuroscience and Biobehavioural Reviews, 35: 1175–85.
Fusar-Poli, P, Bonoldi, I, Yung, AR, et al. (2012) Meta-analysis of transition outcomes in individuals at high clinical risk. Archives of General Psychiatry, 69: 220–29.
Fusar-Poli, P, Borgwardt, S, Bechdolf, A, et al. (2013) The psychosis high-risk state: a comprehensive state-of-the-art-review. JAMA Psychiatry, 70: 107–20.
Gandal, MJ, Haney, JR, Parikshak, NN, et al. (2018) Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science, 359: 693–7.
Giannitelli, M, Consoli, A, Raffin, M, et al. (2018) An overview of medical risk factors for childhood psychosis: implications for research and treatment. Schizophrenia Research, 192: 39–49.
Giaroli, G, Bass, N, Strydom, A, et al. (2014) Does rare matter? Copy number variants at 16p11.2 and the risk of psychosis: a systematic review of literature and meta-analysis. Schizophrenia Research, 159: 340–6.
Gothelf, D, Law, AJ, Frisch, A, et al. (2014) Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome. Biological Psychiatry, 75: 406–13.
Gutiérrez-Fernández, J, del Castillo, JDL, Mañanes-González, S, et al. (2015) Different presence of Chlamydia pneumoniae, herpes simplex virus type I, human herpes virus 6, and Toxoplasma gondii in schizophrenia: meta-analysis and analytical study. Neuropsychiatric Diseases and Treatment, 11: 843–52.
Hameed, MA, Lewis, AJ (2016) Offspring of parents with schizophrenia: a systematic review of developmental features across childhood. Harvard Review of Psychiatry, 24: 104–17.
He, P, Chen, G, Guo, C, et al. (2018) Long-term effect of prenatal exposure to malnutrition on risk of schizophrenia in adulthood: evidence from the Chinese famine of 1959–1961. European Psychiatry, 51: 42–7.
Hilker, R, Helenius, D, Fagerlund, B, et al. (2018) Heritability of schizophrenia and schizophrenia spectrum based on the nationwide Danish twin register. Biological Psychiatry, 83: 492–8.
Howes, OD, McCutcheon, R, Owen, MJ, et al. (2017) The role of genes, stress and dopamine in the development of schizophrenia. Biological Psychiatry, 81: 9–20.
Ingason, A, Rujescu, D, Cichon, S, et al. (2011) Copy number variants of chromosome 16p13.1 region associated with schizophrenia. Molecular Psychiatry, 16(1): 17–25.
Janecka, M, Mill, J, Basson, MA, et al. (2017) Advanced paternal age effects in neurodevelopmental disorders – review of potential underlying mechanisms. Translational Psychiatry, 7: e1019.
Keshavan, MS, Mehta, UM, Padmanabhan, JL, et al. (2015) Dysplasticity, metaplasticity, and schizophrenia: implications for risk, illness, and novel interventions. Development and Psychopathology, 27: 615–35.
Khandaker, GM, Zimbron, J, Dalman, C, et al. (2012) Childhood infection and adult schizophrenia: a meta-analysis of population-based studies. Schiophrenia Research, 139: 161–8.
Kimoto, S, Glausier, JR, Fish, KN, et al. (2016) Reciprocal alterations in regulator of G protein signalling 4 and microRNA16 in schizophrenia. Schizophrenia Bulletin, 42: 396–405.
Kinoshita, M, Numata, S, Tajima, A, et al. (2016) Cumulative effect of the plasma total homocysteine-related genetic variants on schizophrenia risk. Psychiatry Research, 246: 833–7.
Kocˇovskà, E, Gaughran, F, Krivoy, A, et al. (2017) Vitamin D deficiency as a potential environmental risk factor in multiple sclerosis, schizophrenia and autism. Frontiers in Psychiatry, 8: 47.
Kotlar, AV, Mercer, KB, Zwick, ME, et al. (2015) New discoveries in schizophrenia genetics reveal neurobiological pathways: a review of recent findings. European Journal of Medical Genetics, 58: 704–14.
Laurens, KR, Luo, L, Matheson, SL, et al. (2015) Common or distinct pathways to psychosis? A systematic review of evidence from prospective studies for developmental risk factors and antecedents of the schizophrenia spectrum disorders and affective psychoses. BMC Psychiatry, 15: 205.
Linszen, MM, Brouwer, RM, Heringa, SM, et al. (2016) Increased risk of psychosis in patients with hearing impairment: review and meta-analyses. Neuroscience and Behavioural Reviews, 62: 1–20.
Miller, B, Messias, E, Miettunen, J, et al. (2010) Meta-analysis of paternal age and schizophrenia risk in male versus female offspring. Schizophrenia Bulletin, 37: 1039–47.
Moreno-De-Luca, D, Mulle, JG, Kaminsky, EB, et al. (2010) Deletion 17q12 is a recurrent copy number variant that confers a high risk of autism and schizophrenia. American Journal of Human Genetics, 87: 618–30.
Mulle, JG (2012) Schizophrenia genetics: progress, at last. Current Opinion in Genetics & Development, 22: 238–44.
Nimgaonkar, VL, Prasad, KM, Chowdari, KV, et al. (2017) The complement system: a gateway to gene–environment interactions in schizophrenia pathogenesis. Molecular Psychiatry, 22: 1554–61.
Owen, MJ, O'Donovan, MC (2017) Schizophrenia and the neurodevelopmental continuum: evidence from genomics. World Psychiatry, 16: 227–35.
Pawelczyk, T, Trafalska, E, Kotlicka-Antczak, M, et al. (2016) The association between polyunsaturated fatty acid consumption and the transition to psychosis in ultra-high risk individuals. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 108: 30–7.
Perry, BI, Upthegrove, R, Thompson, A, et al. (2018) Dysglycaemia, inflammation and psychosis: findings from the UK ALSPAC Birth Cohort. Schizophrenia Bulletin, Apr 9: doi 10.1093/schbul/sby040 [Epub ahead of print].
Prats, C, Arias, B, Moya-Higueras, J, et al. (2017) Evidence of an epistatic effect between Dysbindin-1 and Neuritin-1 genes on the risk for schizophrenia spectrum disorders. European Psychiatry, 40: 60–4.
Rice, SM, Schäfer, MR, Klier, C, et al. (2015) Erythrocyte polyunsaturated fatty acid levels in young people at ultra-high risk for psychotic disorder and healthy adolescent controls. Psychiatry Research, 228: 174–6.
Riglin, L, Collishaw, S, Richards, A, et al. (2017) Schizophrenia risk alleles and neurodevelopmental outcomes in childhood: a population-based cohort study. Lancet Psychiatry, 4: 57–62.
Romain, K, Eriksson, A, Onyon, R, et al. (2019a) The psychosis risk timeline: can we improve our preventive strategies? Part 2: adolescence and adulthood. BJPsych Advances, 25.
Romain, K, Eriksson, A, Onyon, R, et al. (2019b) The psychosis risk timeline: can we improve our preventive strategies? Part 3: primary common pathways and preventive strategies. BJPsych Advances, 25.
Roseboom, TJ, Painter, RC, van Abeelen, AF, et al. (2011) Hungry in the womb: what are the consequences? Lessons from the Dutch famine. Maturitas, 70: 141–5.
Russak, OD, Ives, L, Mittal, VA, et al. (2016) Fluctuating dermatoglyphic asymmetries in youth at ultrahigh-risk for psychotic disorders. Schizophrenia Research, 170: 301–3.
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) Biological insights from 108 schizophrenia – associated genetic loci. Nature, 511: 421–7.
Schneider, M, Debbané, M, Bassett, AS, et al. (2014) Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behaviour in 22q11.2 Deletion Syndrome. American Journal of Psychiatry, 171: 627–39.
Sebat, J, Levy, DL, McCarthy, SE (2009) Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends in Genetics, 25: 528–35.
Singh, T, Kurki, MI, Curtis, D, et al. (2016) Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders. Nature Neuroscience, 19: 571–7.
Stefansson, H, Rujescu, D (2008) Large recurrent microdeletions associated with schizophrenia. Nature, 455: 232–6.
Sun, GY, Simonyi, A, Fritsche, KL, et al. (2018) Docosahexaenoic acid (DHA): an essential nutrient and a nutraceutical for brain health and diseases. Prostaglandins, Leukotrienes and Essential Fatty Acids, 136: 3–13.
Tam, GW, Redon, R, Carter, NP, et al. (2009) The role of DNA copy number variation in schizophrenia. Biological Psychiatry, 66: 1005–12.
Thompson, CA, Karelis, J, Middleton, FA, et al. (2017) Associations between neurodevelopmental genes, neuroanatomy, and ultra high risk symptoms of psychosis in 22q11.2 deletion syndrome. Americal Journal of Medical Genetics Part B, 174: 295–314.
Vacic, V, McCarthy, S, Malhotra, D, et al. (2011) Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature, 471: 499–503.
van der Werf, M, Hanssen, M, Köhler, S, et al. (2012) Systemic review and collaborative recalculation of 133 693 incident cases of schizophrenia. Psychological Medicine, 44: 9–16.
Vassos, E, Di Forti, M, Coleman, J, et al. (2017) An examination of polygenic score risk prediction in individuals with first episode psychosis. Biological Psychiatry, 81: 470–77.
Viertiö, S, Laitinen, A, Perälä, J, et al. (2007) Visual impairment in persons with psychotic disorder. Social Psychiatry and Psychiatric Epidemiology, 42: 902–8.
Weinstein, Y, Levav, I, Gelkopf, M, et al. (2018) Association of maternal exposure to terror attacks during pregnancy and the risk of schizophrenia in the offspring: a population-based study. Schizophrenia Research, 199: 163–7.
Zhang, S, Zheng, F, You, Y, et al. (2016) Growth arrest specific gene 7 is associated with schizophrenia and regulates neuronal migration and morphogenesis. Molecular Brain, 9: 54.